Cite
HARVARD Citation
MacDonald, L. et al. (2018). Type III hypersensitivity reactions to a B cell epitope antigen are abrogated using a depot forming vaccine platform. Human vaccines & immunotherapeutics. 14 (1), pp. 59-66. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
MacDonald, L. et al. (2018). Type III hypersensitivity reactions to a B cell epitope antigen are abrogated using a depot forming vaccine platform. Human vaccines & immunotherapeutics. 14 (1), pp. 59-66. [Online].